The long-term goal of this project is to expand the range of therapies for bacterial infections that: 1) can effectively treat even antibiotic-resistan organisms; and 2) do not contribute to the further development of antibiotic resistance. This project will explore a new approach using photodynamic therapy for urinary tract infections in people who use catheters for medical purposes. Over a million cases of urinary tract infections are diagnosed each year in this population, and the repeated use of antibiotics to treat these infections is contributing to the spread of drug-resistant organisms. This new approach combines two common and inexpensive drugs (methylene blue, MB and potassium iodide, KI) that will be delivered to the bladder of infected patients and then will be activated by a fiber-opic light source introduced into the bladder. This newly discovered drug combination is synergistic and KI enhances killing by up to 1000-fold compared to the killing using light and MB alone. The light treatment should be applied almost immediately after drug treatment to spare the normal bladder tissue. This approach may enable the eradication of urinary tract infections without the use of antibiotics and without the potential to encourage development of additional treatment resistant in target organisms. Only initial bench studies have been done on the use of photodynamic therapy to treat urinary tract infections. Therefore, the specific aims of this projec are to show that the specific drug combination activated by light can effectively kill a range of bacteria that cause urinary tract infections, including those that are antibiotic-resistant; and tht this photodynamic therapy can be used to eradicate bacterial infections without causing significant damage to the bladder. In the first phase of this project studies will be done with an already-identified drug combination, testing it in bacterial cultures and in small animal models. I the second phase of the project, studies will be done to identify new second generation drug combinations and less expensive LED light sources in order to make treatment more effective and less expensive. Finally, an optimized treatment combination will be tested in a pig model, where the bladder is similar to a human bladder, to show that the photodynamic therapy can eradicate the same kind of bacteria that infect people who have urinary tract infections caused by catheter use.

Public Health Relevance

Over a million cases of urinary tract infections are diagnosed each year in people who use urinary catheters for medical purposes, and the repeated use of antibiotics to treat these infections contributes to the spread of antibiotic-resistant bacteria. Tis project addresses U.S. public health by investigating a different method of killing bacteria and treating bladder infections that does not use antibiotics and does not contribute to the further development of antibiotic resistance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI121700-02
Application #
9180682
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Ernst, Nancy L
Project Start
2015-12-01
Project End
2018-05-31
Budget Start
2016-12-01
Budget End
2018-05-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Hamblin, Michael R (2018) Fullerenes as photosensitizers in photodynamic therapy: pros and cons. Photochem Photobiol Sci 17:1515-1533
Malekzad, Hedieh; Mirshekari, Hamed; Sahandi Zangabad, Parham et al. (2018) Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems. Crit Rev Biotechnol 38:47-67
Hamblin, Michael R; Abrahamse, Heidi (2018) Can light-based approaches overcome antimicrobial resistance? Drug Dev Res :
Lan, Ting; Xiao, Yan; Tang, Li et al. (2018) Treatment of atrophic acne scarring with fractional micro-plasma radio-frequency in Chinese patients: A prospective study. Lasers Surg Med 50:844-850
Ramos, Loyanne C B; Rodrigues, Fernando P; Biazzotto, Juliana C et al. (2018) Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex. J Biol Inorg Chem 23:903-916
Ferraresi, Cleber; Bertucci, Danilo; Schiavinato, Josiane et al. (2018) Reply to the Letter to the Editor on ""Effects of Light-Emitting Diode Therapy on Muscle Hypertrophy, Gene Expression, Performance, Damage, and Delayed-Onset Muscle Soreness: Case-Control Study With a Pair of Identical Twins"". Am J Phys Med Rehabil 97:e2-e5
Huang, Ying-Ying; Wintner, Anton; Seed, Patrick C et al. (2018) Antimicrobial photodynamic therapy mediated by methylene blue and potassium iodide to treat urinary tract infection in a female rat model. Sci Rep 8:7257
Huang, Liyi; Xuan, Weijun; Zadlo, Andrzej et al. (2018) Antimicrobial photodynamic inactivation is potentiated by the addition of selenocyanate: Possible involvement of selenocyanogen? J Biophotonics 11:e201800029
Narita, Kouji; Asano, Krisana; Morimoto, Yukihiro et al. (2018) Corrigendum to ""Disinfection and healing effects of 222-nm UVC light on methicillin-resistant Staphylococcus aureus infection in mouse wounds"" [J. Photochem. Photobiol. B Biol. 178 (January 2018) 10-18]. J Photochem Photobiol B 182:146
Tatmatsu-Rocha, José Carlos; Tim, Carla Roberta; Avo, Lucimar et al. (2018) Mitochondrial dynamics (fission and fusion) and collagen production in a rat model of diabetic wound healing treated by photobiomodulation: comparison of 904?nm laser and 850?nm light-emitting diode (LED). J Photochem Photobiol B 187:41-47

Showing the most recent 10 out of 95 publications